According to the literature, many cases defined as euglycemic diabetic ketoacidosis, which are not attributed to SGLT2 inhibitors, may actually describe diabetic ketoacidosis with overlapping metabolic derangements [4]. This evidence concerns the gene SLC5A2 and diabetic ketoacidosis.